--- 
title: Immune-mediated diseases 
layout: default 
permalink: /immuniverse/
--- 

# Immune-mediated diseases

## ImmUniverse Map

**Development status:** Active development  
**Diseases:** Ulcerative colitis and atopic dermatitis  
**Disease IDs for ulcerative colitis:** [DOID:8577](https://disease-ontology.org/?id=DOID:8577), [MESH:D003093](https://www.ncbi.nlm.nih.gov/mesh/D003093), [MONDO:0005101](https://www.ebi.ac.uk/ols/ontologies/mondo/terms?short_form=MONDO_0005101)  
**Disease IDs for atopic dermatitis:** [DOID:3310](https://disease-ontology.org/?id=DOID:3310), [MESH:D003876](https://www.ncbi.nlm.nih.gov/mesh/D003876), [MONDO:0011292](https://www.ebi.ac.uk/ols/ontologies/mondo/terms?short_form=MONDO_0011292)  
**Sustainable support:** [LCSB](http://wwwen.uni.lu/lcsb), [MINERVA Platform](https://minerva.pages.uni.lu/)  
**Construction tool:** [CellDesigner](https://www.celldesigner.org/)  
**License:** [Creative Commons Attribution 4.0 International (CC BY 4.0) License](https://creativecommons.org/licenses/by/4.0/)  
**Funding:** [IMI2 ImmUniverse No 853995](https://www.imi.europa.eu/projects-results/project-factsheets/immuniverse), [ImmUniverse](https://www.immuniverse.eu/)  
**Contact:** Marcio Luis Acencio, University of Luxembourg, Luxembourg, marcio.acencio(at)uni.lu  

### Description

The ImmUniverse Map is developed within the IMI2 [ImmUniverse](https://www.immuniverse.eu/) project. The ImmUniverse project focuses on ulcerative colitis and atopic dermatitis towards new insights into disease severity and progression with the ultimate aim of improved diagnostic and therapeutic options for patients.

### Funding

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853995.
